suPARnostic® TurbiLatex now CE-IVD approved on Siemens Healthineers ADVIA® XPT Chemical Diagnostics System

Wed Jan 22 2020

ViroGates announces that it has completed the development and regulatory approval (CE-IVD) of its suPARnostic® TurbiLatex product for the ADVIA® Chemistry XPT System from Siemens Healthineers.

This is ViroGates’ first validation of the suPARnostic® TurbiLatex product for a Siemens Healthineers instrument. Siemens Healthineers is one of the leading players in the global  in-vitro diagnostics market.

ViroGates’ suPARnostic® TurbiLatex product can now be implemented in clinical routine use at hospitals using the ADVIA XPT systems.

The ADVIA XPT is one of the automated clinical chemistry analysers placed in laboratories at the hospitals.  The system can run up to 2,400 samples per hour and work as a fully automated system, requiring no manual handling from the blood sampling until results are processed.

The approval of suPARnostic® TurbiLatex for the ADVIA XPT platform complements the previous approvals for the Roche Diagnostics cobas systems.

The suPARnostic® TurbiLatex product is based on a technology called turbidimetry, that measures the loss of intensity of transmitted light due to the scattering effect of particles suspended in the blood sample.

suPARnostic® TurbiLatex is a particle-enhanced turbidimetric assay. The principle of measuring blood samples by using turbidimetry is important in relation to immunoassays. It is the basis of almost all central laboratory clinical chemistry instrument platforms in hospitals.


published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 4 products:

Quick Triage

A Point of Care Solution


For Automated Systems


Clinical and Research

suPARnostic POC+


Point-of-care finger prick

suPAR is used in clinical routine in 48 hospitals

48 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling.
This period covers January 1, 2022, until December 31, 2022. Some hospital locations cannot be disclosed due to confidentiality.

New Webinar


Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates